The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
Enhertu first secured approval in 2019 for patients with high levels of HER2, a protein that promotes cancer cell growth. In ...
In February, Enhertu scored its first phase 3 win in HER2-low breast cancer in the DESTINY-Breast04 ... ADC – Padcev (enfortumab vedotin) – for metastatic urothelial cancers, adding a third ...
The oral HER2 therapy was first approved in 2020 as a combination with trastuzumab and capecitabine for second-line or later treatment of adult patients with advanced or metastatic HER2-positive ...
Verywell Health on MSN51m
Navigating Care Through Every Phase of Metastatic Breast CancerIf you have metastatic breast cancer, you may need help from loved ones and your medical team along the way. Here’s how to ...
Verywell Health on MSN56m
8 Ways to Combat Isolation With a Metastatic Breast Cancer DiagnosisSeveral studies show that isolation is very common among those diagnosed with metastatic breast cancer. However, there are ...
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...
Evan Y. Yu, MD, discusses the therapeutic options for metastatic castration-resistant prostate cancer (mCRPC) included in the National Comprehensive Cancer Network (NCCN) guidelines, such as ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback